| 摘要 |
The invention concerns a human monoclonal antibody characterised in that it exhibits neutralising properties towards the influenza virus and more particularly strains A and B whatever the type of seasonal strains, or a fragment thereof. The invention also concerns hybridomas producing it, compositions containing it and their use in preventive and/or curative therapy or in diagnosis. |
